There’s more to Market Access than pulling together the thickest possible value dossier
Maximizing the value of health technologies requires making the right decisions at the right time. We apply best-in-class strategy development methods tailored to your needs.
When Orphans Grow UpA major global pharmaceutical client is commercializing an ultra-orphan drug for a rare neurodegenerative disorder. Following new clinical data, they approached Inbeeo to aid in defining their pricing strategy in a new and much larger target population.
The Challenge: The new indication potentially represents an unprecedented increase in the size of the treated population for an ultra-orphan drug.
Our Approach: Inbeeo developed a two-step approach that was tailored to the client’s unique challenge based on:
- A pricing dashboard powered by an exhaustive in-depth quantitative analysis of analogue products
- A series of scenario planning workshops with the client multifunctional team
Our Impact: Inbeeo established the client’s asset situation to be truly unprecedented and there was no appropriate analogue they could benchmark their strategy against. The insights provided lead to a rethinking of the project focus on the identification of innovative payment models.
Click Here to explore our case studies portfolio.